Caracterización epidemiológica de pacientes con preeclampsia severa y sus desenlaces. Hospital Universitario Mayor Méderi 2015-2019

Simple item page
dc.creatorFlorez-Herrera, Stephanie
dc.creatorJiménez Rodríguez, Juan Sebastián
dc.date2020-07-03
dc.date2020-07-17T18:54:53Z
dc.date.accessioned2023-11-21T16:20:24Z
dc.date.available2023-11-21T16:20:24Z
dc.descriptionIntroducción: La Preeclampsia es una de las principales causas de morbimortalidad materna y perinatal en el mundo con potenciales consecuencias graves para la madre y el feto. Objetivo: Describir las características clínicas y los desenlaces maternos y neonatales tempranos de pacientes con Preeclampsia severa manejadas en el Hospital Universitario Mayor- Méderi Materiales y Métodos: Estudio retrospectivo de corte transversal. Se incluyeron 385 pacientes seleccionadas al azar del total de pacientes con diagnóstico de Preeclampsia severa acorde a los criterios vigentes. Se incluyeron variables demográficas, clínicas, desenlaces maternos, neonatales tempranos y manejo. Se utilizó estadística descriptiva y se exploraron posibles diferencias entre grupos. El protocolo fue aprobado por el comité de investigación del hospital y comité de ética de la Universidad del Rosario. Resultados: El promedio de edad de las pacientes fue de 28 años DE 6.28, la mayoría nulíparas 65.45% (IC 95% 60.77;70.45), sin antecedentes relevantes. Presentaron cuadro de aparición tardía (mayor a 34 semanas) en 62.33% de los casos (IC 95%57.66;67.50). Dentro de los desenlaces maternos se identifico la necesidad de antihipertensivos al alta en un 85% (IC 9581.67;88.56), seguido de parto por cesárea en un 83.72% (IC 80.31;87.50). El promedio de peso fetal al nacer fue de 2281 DE 837.73. Las variables asociadas a desenlaces maternos y fetales fueron consistentes con las características de la enfermedad. Conclusiones: Este estudio caracterizó la clínica y los desenlaces de la Preeclampsia severa del Hospital Universitario Mayor-Méderi, siendo una muestra representativa de la población de maternas con esta condición en la institución.
dc.descriptionBackground: Preeclampsia is one of the main causes of maternal and perinatal morbidity and mortality in the world with possible serious consequences for the mother and fetus Methodology: Retrospective cross-sectional study. 385 randomly selected patients were included from the total number of patients with a diagnosis of severe pre-eclampsia according to the current criteria. Demographic, clinical variables, maternal, early neonatal outcomes, and management were included. Descriptive statistics were used and possible differences between groups were explored. The protocol was approved by the hospital's research committee and the ethics committee of the Universidad del Rosario. Results: The mean age of the patients was 28 years SD 6.28, the majority nulliparous 65.45% (95% CI 60.77; 70.45), with no relevant history. They presented a late onset (greater than 34 weeks) in 62.33% of cases (95% CI 57.66; 67.50). Among the maternal outcomes, the need for antihypertensive drugs at discharge was identified in 85% (CI 9581.67; 88.56), followed by cesarean delivery in 83.72% (CI 80.31; 87.50). The average fetal weight at birth was 2281 SD 837.73. The variables associated with maternal and fetal outcomes were consistent with the characteristics of the disease. Conclusion: This study characterized the clinic and outcomes of severe Preeclampsia at the Hospital Universitario Mayor-Méderi, being a representative sample of the maternal population with this condition at the institution
dc.formatapplication/pdf
dc.identifierhttps://doi.org/10.48713/10336_25468
dc.identifierhttps://repository.urosario.edu.co/handle/10336/25468
dc.identifier.urihttp://repository-salesiana.heoq.net/handle/123456789/275031
dc.languagespa
dc.publisherUniversidad del Rosario
dc.publisherFacultad de Medicina
dc.publisherEspecialización en Ginecología y Obstericia
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourceSibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365(9461):785–99
dc.sourceEnglish FA, Kenny LC, McCarthy FP. Risk factors and effective management of preeclampsia. Integr Blood Press Control. 2015;8:7–12.
dc.sourceRoberts JM, Druzin M, August PA, Gaiser RR, Bakris G, Granger JP, et al. ACOG Guidelines: Hypertension in pregnancy. American College of Obstetricians and Gynecologists. 2012. 1– 100 p
dc.sourceSecretaría Distrital de Salud. Guía de trastornos hipertensivos del embarazo. Secr Dist Salud Bogotá DC. 2014;24.
dc.sourceLeslie MS, Briggs LA. Preeclampsia and the Risk of Future Vascular Disease and Mortality: A Review. J Midwifery Womens Health. 2016;61(3):315–24.
dc.sourceAbroug F, Boujdaria R, Nouira S, Abroug S, Souissi M, Najjar MF, et al. Hellp syndrome: Incidence and maternal-fetal outcome-a prospective study. Intensive Care Med. 1992;18(5):274–7.
dc.sourceDuley L. The Global Impact of Pre-eclampsia and Eclampsia. Semin Perinatol [Internet]. 2009;33(3):130–7. Available from: http://dx.doi.org/10.1053/j.semperi.2009.02.010
dc.sourceReyes LM, García RG, Ruiz SL, Camacho PA, Ospina MB, Aroca G, et al. Risk factors for preeclampsia in women from Colombia: A case-control study. PLoS One. 2012;7(7):1–8.
dc.sourceMagee LA, Pels A, Helewa M, Rey E, Von Dadelszen P, Audibert F, et al. The hypertensive disorders of pregnancy (29.3). Best Pract Res Clin Obstet Gynaecol. 2015;29(5):643–57.
dc.sourceJames M Roberts, Phyllis A August, George Bakris JRB. Hypertension in Pregnancy. Cardiol Clin. 2012;30(3):407–23.
dc.sourceMol BWJ, Roberts CT, Thangaratinam S, Magee LA, De Groot CJM, Hofmeyr GJ. Preeclampsia. Lancet. 2016;387(10022):999–1011.
dc.sourceHutcheon JA, Lisonkova S, Joseph KS. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol. 2011;25(4):391– 403.
dc.sourceGrupo Desarrollador de la Guía - Universidad Nacional de Colombia - Alianza Cinets. Guía De Práctica Clínica Para El Abordaje De Las Complicaciones Hipertensivas Asociadas Al Embarazo. Rev Colomb Obstet Ginecol. 2013;64(3):289–326.
dc.sourceKuklina E V., Ayala C, Callaghan WM. Hypertensive disorders and severe obstetric morbidity in the united states. Obstet Gynecol. 2009;113(6):1299–306.
dc.sourceDuckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: Systematic review of controlled studies. Br Med J. 2005;330(7491):565–7.
dc.sourceKassebaum NJ, Bertozzi-Villa A, Coggeshall MS, Shackelford KA, Steiner C, Heuton KR, et al. Global, regional, and national levels and causes of maternal mortality during 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9947):980–1004.
dc.sourceNathan HL, Seed PT, Hezelgrave NL, De Greeff A, Lawley E, Conti-Ramsden F, et al. Maternal and perinatal adverse outcomes in women with pre-eclampsia cared for at facilitylevel in South Africa: a prospective cohort study. J Glob Health. 2018;8(2).
dc.sourceCreanga AA, Berg CJ, Syverson C, Seed K, Bruce FC, Callaghan WM. Pregnancy-related mortality in the United States, 2006-2010. Obstet Gynecol. 2015;125(1):5–12.
dc.sourceShih T, Peneva D, Xu X, Sutton A, Triche E, RA E, et al. The Rising Burden of Preeclampsia in the United States Impacts Both Maternal and Child Health. PG - 329-38 LID - 10.1055/s0035-1564881 [doi]. Am J Perinatol. 2016;1(1098-8785 (Electronic))
dc.sourceSeacrist MJ, Morton CH, VanOtterloo LR, Main EK. Quality Improvement Opportunities Identified Through Case Review of Pregnancy-Related Deaths From Sepsis. JOGNN - J Obstet Gynecol Neonatal Nurs. 2019;48(3):311–20.
dc.sourceBakwa-Kanyinga F, Valério EG, Bosa VL, Alfama CO, Sperb M, Capp E, et al. Adolescent pregnancy: Maternal and fetal outcomes in patients with and without preeclampsia. Pregnancy Hypertens. 2017;10:96–100.
dc.sourceBilano VL, Ota E, Ganchimeg T, Mori R, Souza JP. Risk factors of pre-eclampsia/eclampsia and its adverse outcomes in low- and middle-income countries: A WHO secondary analysis. PLoS One. 2014;9(3):1–9.
dc.sourceMonsalve GA, Martínez CM, Gallo T, González MV, Arango G, Upegui A, et al. Maternal critical care: Outcomes and patient characteristics in a combined obstetric high dependency unit in Medellín, Colombia. Rev Colomb Anestesiol. 2011;39(2):190–205.
dc.sourceMogollon-saker S, Salcedo-Ramos F, Ramos-Clason E. Resultados materno perinatales de la preeclampsia lejos del término . Clínica de maternidad Rafael Calvo. Cartagena. Colombia. Ciencias Biomédicas. 2011;2(2):262–9.
dc.sourceMartínez Sánchez LM, Agudelo Vélez CA, Rodríguez-Gázquez MÁ, Cardona Vélez J, Becerra Uribe DE, Palacio Gómez D, et al. Perfil clínico y epidemiológico de pacientes con preeclampsia atendidas en una clínica privada de Medellín, Colombia (2005-2010). Clin Invest Ginecol Obstet [Internet]. 2014;41(2):66–70. Available from: http://dx.doi.org/10.1016/j.gine.2013.03.005
dc.sourceEastabrook G, Brown M, Sargent I. The origins and end-organ consequence of pre-eclampsia. Best Pract Res Clin Obstet Gynaecol. 2011;25(4):435–47
dc.sourceSilasi M, Cohen B, Karumanchi SA, Rana S. Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia. Obstet Gynecol Clin North Am. 2010;37(2):239–53.
dc.sourceSarosh, Rana. Ananth K. Pathophysiology of Preeclampsia [Internet]. Fifth Edit. Vol. 18, Fetal and Neonatal Physiology (Fifth Edition). Elsevier Inc.; 2017. Pages 1724-1732.e2. Available from: http://dx.doi.org/10.1016/B978-0-323-35214-7.00172-4
dc.sourceVidaeff A, Espinoza J. Chronic Hypertension in Pregnancy. Obstet Gynecol. 2019;133(1):1– 25.
dc.sourceSutton ALM, Harper LM, Tita ATN. Hypertensive Disorders in Pregnancy. Obstet Gynecol Clin North Am [Internet]. 2018;45(2):333–47.
dc.sourceLeavitt K, Običan S, Yankowitz J. Treatment and Prevention of Hypertensive Disorders During Pregnancy. Clin Perinatol. 2019
dc.sourceSibai BM. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): Much ado about nothing? Am J Obstet Gynecol [Internet]. 1990;162(2):311–6
dc.sourceKongwattanakul K, Saksiriwuttho P, Chaiyarach S, Thepsuthammarat K. Incidence, characteristics, maternal complications, and perinatal outcomes associated with preeclampsia with severe features and hellp syndrome. Int J Womens Health. 2018;10:371–7.
dc.sourceDurugkar K. A study of maternal and perinatal outcome in cases of HELLP and partial HELLP syndrome. Int J Reprod Contraception, Obstet Gynecol. 2017;6(12):5491.
dc.sourceEdlow AG, Edlow BL, Edlow JA. Diagnosis of Acute Neurologic Emergencies in Pregnant and Postpartum Women. Emerg Med Clin North Am. 2016;34(4):943–65.
dc.sourceBollig KJ, Jackson DL. Seizures in Pregnancy. Obstet Gynecol Clin North Am [Internet]. 2018;45(2):349–67.
dc.sourcePauli JM, Repke JT. Preeclampsia: Short-term and Long-term Implications. Obstet Gynecol Clin North Am. 2015;42(2):299–313.
dc.sourceStory L, Nelson-Piercy C. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. Obstet Med. 2018;11(2):90–1.
dc.sourceAmerican College of Obstetricians and Gynecologists Bulletin. Gestational Hypertension and Preeclampsia. Am Coll Obstet Gynecol. 2019;95(76):1–9.
dc.sourceGuzmán-Yara YN, Parra-Amaya E, Javela-Rugeles JD, Barrios-Torres JC, Montalvo-Arce C, Perdomo-Sandoval HL. Expectant management in non-severe pre-eclampsia, obstetric and perinatal outcomes in a high complexity hospital in Neiva (Colombia). Rev Colomb Obstet Ginecol. 2018;69(3):160–8.
dc.sourceRodríguez-Hernández PA, Beltrán-Avendaño MA. Aproximación a la farmacología del sulfato de magnesio desde la perspectiva obstétrica. MedUNAB. 2016;19(1):25–32.
dc.sourceNICE. Hypertension in pregnancy : diagnosis and management. Am J Obs Gynecol [Internet]. 2019;77(1):S1-s22.
dc.sourceAyçaguer LCS. Muestreo para la investigación en ciencias de la salud. Santos D de, editor. 1993. 159 p.
dc.source59a Asamblea General, Seúl C. Declaración de Helsinki de la Asociación Médica Mundial. Principios éticos para las investigaciones médicas en seres humanos. 2008.
dc.sourceResolución 8430. Minist salud Colomb. 1993;32
dc.sourceSibai BM, Caritis S, Hauth J. What we have learned about preeclampsia. Semin Perinatol. 2003;27(3):239–46.
dc.sourceBeltrán Chaparro LV, Benavides P, López Rios JA, Onatra Herrera W. Estados hipertensivos en el embarazo: revisión. Rev UDCA Actual Divulg Científica. 2014;17(2):311–23.
dc.sourceVargas H. VM, Acosta A. G, Moreno E. MA. La preeclampsia un problema de salud pública mundial. Rev Chil Obstet Ginecol. 2012;77(6):471–6
dc.sourceStubert J, Ullmann S, Dieterich M, Diedrich D, Reimer T. Clinical differences between earlyand late-onset severe preeclampsia and analysis of predictors for perinatal outcome. J Perinat Med. 2014;42(5):617–27.
dc.sourceDolea C, Abouzahr C. Global burden of hypertensive disorders of pregnancy in the year 2000. Glob Burd Dis. 2003;1–11.
dc.sourceMatthys LA, Coppage KH, Lambers DS, Barton JR, Sibai BM. Delayed postpartum preeclampsia: An experience of 151 cases. Am J Obstet Gynecol. 2004;190(5):1464–6.
dc.sourceColombia M de salud. Resolución No. 3280. 2018.
dc.sourceYildirim G, Güngördük K, Aslan H, Gül A, Bayraktar M, Ceylan Y. Comparison of perinatal and maternal outcomes of severe preeclampsia, eclampsia, and HELLP syndrome. J Turkish Ger Gynecol Assoc. 2011;12(2):90–6.
dc.sourceCuriel-Balsera E, Prieto-Palomino MA, Muñoz-Bono J, Ruiz de Elvira MJ, Galeas JL, Quesada García G. Análisis de la morbimortalidad materna de las pacientes con preeclampsia grave, eclampsia y síndrome HELLP que ingresan en una Unidad de Cuidados Intensivos gineco-obstétrica. Med Intensiva. 2011;35(8):478–83.
dc.sourcePhoa KYN, Chedraui P, Pérez-López FR, Wendte JF, Ghiabi S, Vrijkotte T, et al. Perinatal outcome in singleton pregnancies complicated with preeclampsia and eclampsia in Ecuador. J Obstet Gynaecol (Lahore). 2016;36(5):581–4.
dc.sourceMooij R, Lugumila J, Mwashambwa MY, Mwampagatwa IH, van Dillen J, Stekelenburg J. Characteristics and outcomes of patients with eclampsia and severe pre-eclampsia in a rural hospital in Western Tanzania: A retrospective medical record study. BMC Pregnancy Childbirth [Internet]. 2015;15(1):1–7.
dc.sourceKonechne T. Cesarean. Perform Res. 2001;6(1):90–3.
dc.sourceinstname:Universidad del Rosario
dc.sourcereponame:Repositorio Institucional EdocUR
dc.subjectPreeclampsia
dc.subjectDesenlaces maternos
dc.subjectSíndrome Hellp
dc.subjectDesenlaces neonatales
dc.subjectFactores de riesgo
dc.subjectIncidencia & prevención de la enfermedad
dc.subjectPreeclampsia
dc.subjectHellp syndrome
dc.subjectMaternal outcomes
dc.subjectNeonatal outcomes
dc.subjectRisk factors
dc.titleCaracterización epidemiológica de pacientes con preeclampsia severa y sus desenlaces. Hospital Universitario Mayor Méderi 2015-2019
dc.titleEpidemiological characterization of patients with severe preeclampsia and its outcomes. Mayor Méderi University Hospital 2015-2019
dc.typeinfo:eu-repo/semantics/masterThesis
dc.typeinfo:eu-repo/semantics/acceptedVersion
Files
Collections
Varias